Low-Volume Interval Training and Resistance Exercise in Individual With Stroke

November 9, 2020 updated by: Mohd Haidzir Abd Manaf, Universiti Teknologi Mara

Feasibility of Low-Volume Interval Training and Resistance Exercise on Walking Performance, Aerobic Fitness, Muscle Strength and Quality Of Life in Individual With Stroke

To examine the feasibility of Low-Volume Interval Training (LV-ITT) and Resistance Exercise (RE) on walking performance (walking endurance, gait speed, functional balance), lower limb muscle strength and quality of life among individuals with post-stroke.

Study Overview

Detailed Description

Prescribing aerobic and resistance training in concurrence is proposed as an optimum strategy to target cardiovascular as well as musculoskeletal functions in individuals with post-stroke. Lower limb's resistance training alone in chronic stroke produces a large effect on muscle strength. However, it has shown uncertainty results on walking performance. Therefore, it is suggested that to prescribe mix training (treadmill training and strength training) in order to improve muscle strength, gait performance and quality of life in stroke survivors. Previous studies have shown the effect of mixed training on walking performance and endurance in other populations such as multiple sclerosis and coronary artery disease. However, there is a lack of study that conducted mixed training among chronic post-stroke. Therefore, the feasibility study on the effectiveness of combining LV-ITT and RE in post-stroke should be conducted.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Selangor
      • Batu Caves, Selangor, Malaysia, 68100
        • Recruiting
        • Hospital Selayang
        • Contact:
        • Sub-Investigator:
          • Norliza Zainudin, MMED

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

45 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Age range between 45-65 years' old
  • At least 3-months post-stroke
  • Gait speed ≤1.0 m·s -¹ measured by the 10 m walk test.
  • Able to walk 10 m overground with assistive devices as needed and no physical assistance.
  • Able to walk for 3 min on the treadmill at ≥0.17 m·s -¹ (0.4 mph) with no aerobic exercise contraindications.
  • Modified Rankin Score (mRS) of <4 at the screening
  • American Heart Association class B (2), allowing for aerobic capacity <6 metabolic equivalent (MET)

Exclusion Criteria:

  • Significant resting ECG abnormalities
  • Hospitalization for cardiac or pulmonary disease within 3 months
  • Using Pacemaker
  • Aphasia
  • Significant musculotendinous or bony restrictions of the affected limb, or any serious chronic disease independently causing disability or profound atrophy of the affected limb that will comprise further indications to participation significant.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention
3 sessions/week for 6 weeks

Low-volume interval training (LV-ITT) protocols included a 5 min warm-up (30%-50%VO2peak) up to 20min of LV-ITT and a 5 min cooling down (30%-50% VO2peak). The LV-ITT will repeat 60s bursts of fast treadmill walking at maximum tolerate speed (0% incline), alternate with pre-specified recovery periods about 4 minutes according to protocol. Each time the participants completed a burst successfully, treadmill speed will be increased by 0.1 mph for the next burst. The recovery periods will be 4 minutes. The intervention will be conducted for about 30 minutes.

Resistance training will be conducted by using a horizontal leg press machine. They are encouraged to focus on an explosive concentric movement and a controlled eccentric movement such that the time on each phase was in the ratio 1:2.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Six Minute Walk Test
Time Frame: 0, 6 weeks
This test measures the distance that an individual can quickly walk in a period of 6 minutes on a flat surface. Participants will complete one trial with the gait aide prescribed to them. The distance will be recorded. Participants can stop and rest or discontinue to the test at any time.
0, 6 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in 10-meter walk test
Time Frame: 0, 6 weeks
This assessment will include four 10-meter walking tasks at maximal comfortable speed.
0, 6 weeks
Change in Lower Limb Muscle Strength
Time Frame: 0, 6 weeks
Handheld dynamometer for knee extensor
0, 6 weeks
Change in Timed Up and Go test
Time Frame: 0, 6 weeks
Functional Balance
0, 6 weeks
Stroke Impact Scale (SIS)
Time Frame: 0,week 6
Quality of Life
0,week 6
Adherence
Time Frame: 0 to 6 weeks
Attendance and completion of home-based sessions measured via exercise diary
0 to 6 weeks
Adverse Events
Time Frame: 0 to 6 weeks
Any adverse event or near miss is required to be reported as standard of care at Selayang Hospital
0 to 6 weeks
Patient satisfaction
Time Frame: 6 weeks
Questionnaire
6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mohd Haidzir Abd Manaf, PhD, Universiti Teknologi Mara

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 1, 2020

Primary Completion (Anticipated)

June 30, 2021

Study Completion (Anticipated)

August 31, 2021

Study Registration Dates

First Submitted

October 20, 2020

First Submitted That Met QC Criteria

November 3, 2020

First Posted (Actual)

November 10, 2020

Study Record Updates

Last Update Posted (Actual)

November 12, 2020

Last Update Submitted That Met QC Criteria

November 9, 2020

Last Verified

November 1, 2020

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stroke

Clinical Trials on Combination of Low-volume interval treadmill training and Resistance Training

3
Subscribe